ArticleExploratory research in clinical and social pharmacy2026
Challenges and best practices in essential medicines supply and use in internally displaced persons (IDP) camps: A qualitative study.
Article in Exploratory research in clinical and social pharmacy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Despite the critical need for effective healthcare in internally displaced persons (IDP) camps in Ethiopia, a significant gap exists between the demand for and the actual provision and management of essential medicines. This challenge is rooted in systemic failures across the medicine supply chain and utilization practices, directly compromising the health and well-being of a highly vulnerable population. This study, therefore, explored the challenges and best practices related to essential medicines supply and use in IDP camps in Ethiopia. Methods: An exploratory qualitative study was conducted among key informants, including healthcare providers, IDP site coordinators, representatives from donor organization and health bureue, and patients from selected IDP camps. Participants were purposively selected to capture diverse perspectives relevant to essential medicine supply and use. The contact information of all potential key informants was obtained through official camp records, IDP camp team leaders, and referrals from key stakeholders. Data were collected through in-depth interviews and analyzed thematically using OpenCode software. Results: The investigator conducted in-depth interviews with 17 key informants. Analysis identified 22 sub-themes grouped under 13 main themes. Key challenges identified included fragile supply chains and procurement process, persistent stock-outs, limited availability, inadequate storage and transportation, weak information management and reporting practices, financial constraints, donor-driven priorities, irrational prescribing and dispensing, fragmented service delivery, poor supervision and accountability mechanisms, and patient and community-level practices such as medicine sharing, self-medication, and incomplete adherence. Best practices that mitigated these challenges included patient identification initiatives, medicine-shifting systems, centralized distribution and cluster-level coordination, structured reporting, strategic allocation, and partnerships between humanitarian actors. Conclusion: Ensuring sustainable access to essential medicines in IDP camps requires integrated strategies that strengthen supply chain resilience, promote rational medicine use, and actively engage communities. Contextually adapted best practices can enhance equitable access, improve treatment adherence, and support the resilience of health systems in protracted IDP camps.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.